Acadia Pharmaceuticals Inc.

US$21.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ACADHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (0.93%)
Div yield —
ROE 31.43%
Biotechnology
Beta (5Y) 0.89
PE TTM 10.15
TSR TTM (6.48%)
Mkt cap US$3.669B
ROIC 26.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$28
29.85%
87.16%
Sell 1|2|4|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.22
0.24
0.25
0.26
11.92%
16.15%
13.52%
20.87%
Revenue$M
356.9
353.8
352.1
345.8
5.79%
1.34%
(2.33%)
(3.60%)
Peers (US$3.669B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.421
2.087
2.114
EBIT/Intx
0.159
0.121
0.153
Own earn%
18.76
29.94
38.18
Sh yield%
40.54
47.75
45.93
Owners
Insiders/Inst%
7.18
31.63
Short interest%
2.30
SBC / revenue%
1.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
4